What is the CVR number of BioPhero ApS?

BioPhero ApS is registered with CVR / Virk under CVR 38109340.

What is the revenue of BioPhero ApS?

BioPhero ApS reported revenue of DKK -3,6M in 2022.

BioPhero ApS employs 28 people as of the latest annual report.

BioPhero ApS's registered address is Lersø Parkallé 42, 4..

APSDissolvedAdvertising protection

CVR 38109340Lersø Parkallé 42, 2100 København ØForskning og eksperimentel udvikling indenfor bioteknologi· NACE 721100Est. 2016 · 9 years old28 employees

Actively employed in the business

Name	Role	Member since
Former (2)
KB Kristian Bitsch Ebbensgaard Chief Executive Officer	Chief Executive Officer	2018 – 2023
MG Michael Gronemann Andersen Management	Management	2016 – 2017

Non-executive oversight

Name	Role	Member since
Former (10)
HM Henrik Meyer Board of Directors	Board of Directors	2018 – 2018
TG Thomas Grotkjær Board of Directors	Board of Directors	2018 – 2022
JH John Hamer Board of Directors	Board of Directors	2021 – 2022
BF Benedicte Francoise Simone Flambard Chairman	Chairman	2022 – 2023
HS Hadyn St Pierre Parry Chairman	Chairman	2018 – 2022
MJ Michael James Lee Board of Directors	Board of Directors	2018 – 2022
HH Helge Holm-Larsen Board of Directors	Board of Directors	2019 – 2021
WF William Francis Chester Board of Directors	Board of Directors	2022 – 2023
PS Peter Smedegaard Chairman	Chairman	2018 – 2018
JL Jakob Lyngsø Andersen Board of Directors	Board of Directors	2022 – 2023

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Syngenta Ventures Pte. Ltd.	Individual	20–24.99%	0%	2018
Novo Holdings A/S	Company	20–24.99%	20–24.99%	2022
Syngenta Ventures Pte. Ltd.	Individual	15–19.99%	15–19.99%	2022
FMC VENTURES BIOPHERO LLC	Individual	5–9.99%	5–9.99%	2022
Uddannelses- og Forskningsstyrelsen	Company	5–9.99%	5–9.99%	2019
Phero Holding ApS	Company	15–19.99%	15–19.99%	2021
CHEMINOVA A/S	Company	100%	100%	2022
Irina Borodina	Individual	100%	100%	2017
BioCH ApS	Company	5–9.99%	5–9.99%	2018
DCVC Bio II, L.P.	Individual	33.33–49.99%	33.33–49.99%	2022
Syngenta Ventures Pte. Ltd.	Individual	15–19.99%	15%	2018
Carina Holkenbrink	Individual	15–19.99%	15–19.99%	2017
Lentge Andersen Holding ApS	Company	33.33–49.99%	33.33–49.99%	2016

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.